|
Volumn 94, Issue , 1996, Pages 433-450
|
The Vanderbilt classification system in the evaluation of diabetic retinopathy patients treated with alredase
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
TOLRESTAT;
ADULT;
AGED;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETIC RETINOPATHY;
DISEASE CLASSIFICATION;
DOUBLE BLIND PROCEDURE;
EYE PHOTOGRAPHY;
FEMALE;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
QUALITY CONTROL;
RANDOMIZED CONTROLLED TRIAL;
RELIABILITY;
ADOLESCENT;
ADULT;
AGED;
ALDEHYDE REDUCTASE;
DIABETES MELLITUS, TYPE 1;
DIABETES MELLITUS, TYPE 2;
DIABETIC RETINOPATHY;
DOUBLE-BLIND METHOD;
ENZYME INHIBITORS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
NAPHTHALENES;
OBSERVER VARIATION;
PROSPECTIVE STUDIES;
REPRODUCIBILITY OF RESULTS;
TENNESSEE;
|
EID: 0029904010
PISSN: 00659533
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (3)
|
References (0)
|